{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:31:53Z","timestamp":1793712713597,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd004034.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000}}],"reference-count":185,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004034.pub4","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T09:00:04Z","timestamp":1621846804000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia"],"prefix":"10.1002","volume":"2021","author":[{"given":"Emma L","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A","family":"Todd","sequence":"additional","affiliation":[{"name":"Care of the Elderly Medicine; Western Health and Social Care Trust; Londonderry UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bullock","sequence":"additional","affiliation":[{"name":"Kingshill Research Centre, Victoria Hospital; Swindon UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[{"name":"Centre for Public Health; Queen's University Belfast; Belfast UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"issue":"12A","key":"10.1002\/14651858.CD004034.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"12A","key":"10.1002\/14651858.CD004034.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"44i","DOI":"10.1016\/j.amjcard.2007.03.005","article-title":"Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"99","author":"Cushman","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD004034.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1002\/14651858.CD004034.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc11-1868","article-title":"Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial","volume":"35","author":"O'Connor","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2013.13656","article-title":"Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial","volume":"174","author":"Williamson","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"12A","key":"10.1002\/14651858.CD004034.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"112i","DOI":"10.1016\/j.amjcard.2007.03.029","article-title":"The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods","volume":"99","author":"Williamson","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinternmed.2011.1391","article-title":"Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double-blind randomized clinical trial","volume":"172","author":"Hajjar","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jgs.12100","article-title":"Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial","volume":"61","author":"Hajjar","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ajh\/hpu161","article-title":"Aldosterone, cognitive function, and cerebral hemodynamics in hypertension and antihypertensive therapy","volume":"28","author":"Hajjar","year":"2015","journal-title":"American Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2318-9-48","article-title":"The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition","volume":"9","author":"Hajjar","year":"2009","journal-title":"BMC Geriatrics"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1536\/ihj.53.244","article-title":"Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial","volume":"53","author":"Sato","year":"2012","journal-title":"International Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/HJH.0b013e32835fdf60","article-title":"Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: results after 1 year","volume":"31","author":"Sato","year":"2013","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2165\/00002512-200118030-00001","article-title":"Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial","volume":"18","author":"Bulpitt","year":"2001","journal-title":"Drugs & Aging"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurology"},{"issue":"26","key":"10.1002\/14651858.CD004034.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1093\/eurheartj\/eht464","article-title":"Treating hypertension in the very elderly-benefits, risks, and future directions, a focus on the hypertension in the very elderly trial","volume":"35","author":"Peters","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002512-200623010-00008","article-title":"A substudy protocol of the Hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG): an ongoing randomised, double-blind, placebo-controlled trial","volume":"23","author":"Peters","year":"2006","journal-title":"Drugs Aging"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0019|cit19","first-page":"117","article-title":"Quality of life in normotensives compared to hypertensive men treated with isradipine or methyldopa as monotherapy or in combination with captopril: the LOMIR-MCT-IL study.","volume":"10","author":"Yodfat","journal-title":"Journal of Human Hypertension"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD004034.pub4-BIB0020|cit20","first-page":"57S","article-title":"A multicenter, double-blind, randomized, placebo-controlled study of isradipine and methyldopa as monotherapy or in combination with captopril in the treatment of hypertension. The LOMIR-MCT-IH Research Group.","volume":"6","author":"Yodfat","journal-title":"American Journal of Hypertension"},{"issue":"6824","key":"10.1002\/14651858.CD004034.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party","volume":"304","author":"MRC Working Party","year":"1992","journal-title":"British Medical Journal"},{"issue":"7034","key":"10.1002\/14651858.CD004034.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/bmj.312.7034.801","article-title":"Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults","volume":"312","author":"Prince","year":"1996","journal-title":"British Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(00)00304-1","article-title":"The effects of propranolol on cognitive function and quality of life: a randomized trial among patients with diastolic hypertension.","volume":"108","author":"P\u00e9rez-Stable","journal-title":"The American Journal Of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.jhh.1001657","article-title":"Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Degl'Innocenti","year":"2004","journal-title":"Journal of Human Hypertension"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub4-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.hjh.0000133730.47372.4c","article-title":"The Study of COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization","volume":"22","author":"Lithell","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomised double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"Journal of Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0027|cit27","first-page":"1175","article-title":"Stroke Prevention With the Angiotension II Type-1 Receptor Blocker Candesartan in Elderly Patients With Isolated Systolic Hypertension. The Study on Cognition and Prognosis in the Elderly (SCOPE)","volume":"44","author":"Papademetriou","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0028|cit28","doi-asserted-by":"crossref","unstructured":"Skoog I Lithell H Hansson L Elmfeldt D Hofman A Olofsson B for the SCOPE Study Group Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE) American Journal of Hypertension 2005 18 1052 1059","DOI":"10.1016\/j.amjhyper.2005.02.013"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1001\/archinte.1994.00420190047006","article-title":"Impact of the Treatment of Isolated Systolic Hypertension on Behavioral Variables. Results From the Systolic Hypertension in the Elderly Program","volume":"154","author":"Applegate","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","article-title":"Dementia and Disability Outcomes in Large Hypertension Trials: Lessons Learned from the Systolic Hypertension in the Elderly Program (SHEP) Trial","volume":"153","author":"Di Bari","year":"2001","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of Stroke by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension. Final Results of the Systolic Hypertension in the Elderly Program (SHEP)","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0895-4356(88)90024-8","article-title":"Rationale and Design of a Randomized Clinical Trial on Prevention of Stroke in Isolated Systolic Hypertension","volume":"41","author":"The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).","volume":"11","author":"Ambrosius","journal-title":"Clinical Trials"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMoa1611179","article-title":"Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes.","volume":"377","author":"Berlowitz","journal-title":"The New England Journal of Medicine"},{"issue":"22","key":"10.1002\/14651858.CD004034.pub4-BIB0035|cit35","first-page":"2103","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control.","volume":"373","author":"Williamson","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jama.2018.21442","article-title":"Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial","volume":"321","author":"The SPRINT MIND Investigators for the SPRINT Research Group","year":"2019","journal-title":"JAMA"},{"issue":"24","key":"10.1002\/14651858.CD004034.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.2016.7050","article-title":"Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged \u226575 Years: A Randomized Clinical Trial.","volume":"315","author":"Williamson","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF03324024","article-title":"Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol, and organization","volume":"3","author":"Amery","year":"1991","journal-title":"Aging Clin Exp Res"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/00004872-200210000-00028","article-title":"Quality of life on randomised treatment for isolated hypertension: results from the Syst-Eur Trial","volume":"20","author":"Fletcher","year":"2002","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00004872-199816080-00006","article-title":"Quality of life of elderly patients with isolated systolic hypertension: baseline data from the Syst-Eur Trial","volume":"16","author":"Fletcher","year":"1988","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The Prevention of Dementia With Antihypertensive Treatment. New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) Trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0043|cit43","first-page":"D17","article-title":"Reduction of dementia by calcium-antagonist-based antihypertensive treatment","volume":"2","author":"Forette","year":"2000","journal-title":"European Heart Journal Supplements"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(97)05381-6","article-title":"Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension","volume":"350","author":"Staessen","year":"1997","journal-title":"The Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jamda.2018.05.025","article-title":"Effect of low dose statins and apolipoprotein E genotype on cerebral small vessel disease in older hypertensive patients: a subgroup analysis of a randomized clinical trial","volume":"19","author":"Ji","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41440-018-0165-7","article-title":"Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial","volume":"42","author":"Zhang","year":"2018","journal-title":"Hypertension research"},{"issue":"9","key":"10.1002\/14651858.CD004034.pub4-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s001250100612","article-title":"Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation","volume":"44","author":"ADVANCE Management Committee","year":"2001","journal-title":"Diabetologia"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eurpsy.2011.07.005","article-title":"Oral disease in relation to future risk of dementia and cognitive decline: prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial","volume":"28","author":"Batty","year":"2013","journal-title":"European Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/HJH.0b013e328338a89c","article-title":"Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial","volume":"28","author":"Ninomiya","year":"2010","journal-title":"Journal of Hypertension"},{"issue":"9590","key":"10.1002\/14651858.CD004034.pub4-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/HYPERTENSIONAHA.114.04421","article-title":"Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation","volume":"65","author":"Van der Leeuw","year":"2015","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000086521.95630.5A","article-title":"Diuretic Versus Alpha-Blocker as First-Step Antihypertensive Therapy. Final Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"42","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2003","journal-title":"Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial","volume":"366","author":"Dahlof","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/hy1101.095000","article-title":"One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension","volume":"38","author":"Black","year":"2001","journal-title":"Hypertension"},{"issue":"26","key":"10.1002\/14651858.CD004034.pub4-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1002\/14651858.CD004034.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jamainternmed.2015.4103","article-title":"Effect of Discontinuation of Antihypertensive Treatment in Elderly People on Cognitive Functioning--the DANTE Study Leiden: A Randomized Clinical Trial","volume":"175","author":"Moonen","year":"2015","journal-title":"JAMA Internal Medicine"},{"issue":"12","key":"10.1002\/14651858.CD004034.pub4-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jch.12435","article-title":"Cerebral blood flow and cognitive function in patients with metabolic syndrome: effect of antihypertensive therapy","volume":"16","author":"Efimova","year":"2014","journal-title":"Journal of Clinical Hypertension (Greenwich, Conn.)"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1755-5922.12136","article-title":"Influence of antihypertensive therapy on cerebral perfusion in patients with metabolic syndrome: relationship with cognitive function and 24-h arterial blood pressure monitoring","volume":"33","author":"Efimova","year":"2015","journal-title":"Cardiovascular Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/HJH.0000000000000853","article-title":"Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke","volume":"34","author":"Zanchetti","year":"2016","journal-title":"Journal Of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1097\/HJH.0000000000000254","article-title":"Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trial","volume":"32","author":"Zanchetti","year":"2014","journal-title":"Journal of Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0061|cit61","first-page":"S501","article-title":"Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly","volume":"3","author":"Amery","year":"1985","journal-title":"Journal of Hypertension. Supplement"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","article-title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) study","volume":"9","author":"Kivipelto","journal-title":"Alzheimer's & Dementia"},{"issue":"9984","key":"10.1002\/14651858.CD004034.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004034.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.jhh.1001613","article-title":"Influence of losartan and atenolol on memory function in very elderly hypertensive patients","volume":"17","author":"Fogari","year":"2003","journal-title":"Journal Of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.jhh.1001964","article-title":"Effect of telmisartan\/hydrochlorothiazide vs lisinopril\/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients","volume":"20","author":"Fogari","year":"2006","journal-title":"Journal Of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.HYP.15.4.361","article-title":"Treatment of hypertension in the elderly: II. Cognitive and behavioral function. Results of a Department of Veterans Affairs Cooperative Study","volume":"15","author":"Goldstein","year":"1990","journal-title":"Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.HYP.15.4.348","article-title":"Treatment of hypertension in the elderly: I. Blood pressure and clinical changes. Results of a Department of Veterans Affairs Cooperative Study","volume":"15","author":"Materson","year":"1990","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-161198","article-title":"Rationale and design of the mechanistic potential of antihypertensives in preclinical Alzheimer's (HEART) trial","volume":"61","author":"Wharton","year":"2018","journal-title":"Journal of Alzheimer's Disease"},{"issue":"13","key":"10.1002\/14651858.CD004034.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e1435","DOI":"10.1212\/WNL.0000000000007174","article-title":"Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study","volume":"92","author":"Bosch","year":"2019","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0070|cit70","first-page":"311","article-title":"Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics","volume":"32","author":"Lonn","year":"2016","journal-title":"The Canadian Journal of Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD004034.pub4-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease","volume":"374","author":"Lonn","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD004034.pub4-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1600177","article-title":"Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"The New England Journal Of Medicine"},{"issue":"9118","key":"10.1002\/14651858.CD004034.pub4-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1016\/S0149-2918(03)80334-X","article-title":"Efficacy and Tolerability of Oral Stevioside in Patients with Mild Essential Hypertension: A Two-Year, Randomised, Placebo-Controlled Study","volume":"25","author":"Chan","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"20","key":"10.1002\/14651858.CD004034.pub4-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.119.041603","article-title":"Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY)","volume":"140","author":"White","year":"2019","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0002-9343(89)90142-3","article-title":"Effects of antihypertensive therapy on blood pressure control, cognition and reactivity. A placebo-controlled comparison of prazosin, propranolol, and hydrochlorothiazide","volume":"86","author":"Lasser","year":"1989","journal-title":"Am J Med"},{"issue":"2 Suppl 1","key":"10.1002\/14651858.CD004034.pub4-BIB0077|cit77","first-page":"S134","article-title":"The LOW-BP-VIENNA (Lowering Blood Pressure in Primary Care in Vienna) trial-rationale and design","volume":"126","author":"Rohla jun","year":"2014","journal-title":"Wiener klinische Wochenschrift"},{"issue":"23-24","key":"10.1002\/14651858.CD004034.pub4-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00508-018-1374-4","article-title":"Lowering blood pressure in primary care in Vienna (LOW-BP-VIENNA) : A cluster-randomized trial","volume":"130","author":"Rohla","year":"2018","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","article-title":"Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies","volume":"10","author":"Anderson","year":"2011","journal-title":"Lancet Neurology"},{"issue":"15","key":"10.1002\/14651858.CD004034.pub4-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","article-title":"Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND) trials","volume":"148","author":"Teo","year":"2004","journal-title":"American Heart Journal"},{"issue":"10046","key":"10.1002\/14651858.CD004034.pub4-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","article-title":"Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial","volume":"388","author":"Moll van Charante","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/jamaneurol.2017.5153","article-title":"Effect of Standard vs Intensive Blood Pressure Control on Cerebral Blood Flow in Small Vessel Disease: The PRESERVE Randomized Clinical Trial","volume":"75","author":"Croall","year":"2018","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","article-title":"Effects of aspirin plus extended-release dipyridamoleversus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study","volume":"7","author":"Diener","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of Blood Pressure Lowering With Perindopril and Indapamide Therapy on Dementia and Cognitive Decline in Patients With Cerebrovascular Disease","volume":"163","author":"The PROGRESS Collaborative Group","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cct.2019.02.007","article-title":"Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study)","volume":"79","author":"Szabo-Reed","year":"2019","journal-title":"Contemporary clinical trials"},{"issue":"12","key":"10.1002\/14651858.CD004034.pub4-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1474-4422(14)70224-8","article-title":"Effects of long-term blood pressure lowering and dual antiplatelet therapy on cognition in patients with recent lacunar stroke: Secondary Prevention of Small Subcortical Strokes (SPS3) trial","volume":"13","author":"Pearce","year":"2014","journal-title":"Lancet Neurology"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1532-5415.1996.tb06412.x","article-title":"The effects of antihypertensive treatment on cognitive function: results from the HOPE study","volume":"44","author":"Starr","year":"1996","journal-title":"Journal of the American Geriatrics Society"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ageing\/22.5.343","article-title":"Hypertensive Old People in Edinburgh (HOPE) Study: electrocardiographic changes after captopril or bendrofluazide treatment","volume":"22","author":"Starr","year":"1993","journal-title":"Age and Ageing"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0140-6736(91)92589-T","article-title":"Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP Hypertension)","volume":"338","author":"Dahlof","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00004872-199816120-00016","article-title":"Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension","volume":"16","author":"Liu","year":"1998","journal-title":"Journal of Hypertension"},{"issue":"(11 Pt 1)","key":"10.1002\/14651858.CD004034.pub4-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0895-7061(99)00156-9","article-title":"Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients","volume":"12","author":"Tedesco","year":"1999","journal-title":"American Journal Of Hypertension"},{"issue":"9644","key":"10.1002\/14651858.CD004034.pub4-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patientsintolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/jch.12094","article-title":"Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years","volume":"15","author":"Wei","year":"2013","journal-title":"Journal Of Clinical Hypertension (Greenwich, Conn)"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18565\/cardio.2016.3.19-24","article-title":"Effect of Combined Antihypertensive Therapy With Perindopril and Indapamide on Morpho-Functional Parameters of The Heart, Blood Vessels of Small and Medium Caliber in Patients With Essential Hypertension","volume":"56","author":"Zheleznyh","year":"2016","journal-title":"Kardiologiia"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004034.pub4-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/01.hjh.0000549367.55414.86","article-title":"Effects of antihypertensive therapy on cognitive function and health-related quality of life in high-risk hypertensive patients","volume":"36","author":"Ma","year":"2018","journal-title":"Journal of Hypertension. Conference: 27th Scientific Meeting of the International Society of Hypertension, ISH"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/11598110-000000000-00000","article-title":"Combination of amlodipine plus angiotensin receptor blocker or diuretics in high-risk hypertensive patients: a 96-week efficacy and safety study","volume":"12","author":"Ma","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/jhh.2010.45","article-title":"The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics","volume":"25","author":"Wang","year":"2011","journal-title":"J Hum Hypertens"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub4-BIB0100|cit100","first-page":"701","article-title":"Effects of amlodipine plus telmisartan or amlodipine plus amiloride regimen on blood pressure control in hypertensive patients: preliminary report of Chinese Hypertension Intervention Efficacy (CHIEF) trial","volume":"37","author":"Wang","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ijs.12085","article-title":"Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of stroke recurrence and longitudinal progression of white matter lesions and silent brain infarcts on MRI (CEREBRAL study): rationale, design, and methodology","volume":"10","author":"Yamano","year":"2015","journal-title":"International Journal of Stroke"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0102|cit102","unstructured":"Effects of Intensive Systolic Blood Pressure Lowering Treatment in Reducing RIsk of Vascular evenTs (ESPRIT) Study (ESPRIT)"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0103|cit103","unstructured":"Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.trci.2019.06.005","article-title":"Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials","volume":"5","author":"Andrews","year":"2019","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0106|cit106","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0107|cit107","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"issue":"3 Pt 2","key":"10.1002\/14651858.CD004034.pub4-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1093\/ajh\/6.3.62S","article-title":"Reexamining the quality of life of hypertensive patients. A new self-structured measure","volume":"6","author":"Bar-On","year":"1993","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jhh.2008.80","article-title":"Cognitive function and hypertension","volume":"23","author":"Birns","year":"2009","journal-title":"Journal of Human Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1532-5415.2002.50104.x","article-title":"Relationship of race\/ethnicity and blood pressure to change in cognitive function","volume":"50","author":"Bohannon","year":"2002","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000017043","article-title":"Vascular risks and incident dementia:results from a cohort study of the very old","volume":"9","author":"Brayne","year":"1998","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0112|cit112","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011145.pub2","article-title":"Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations","author":"Creavin","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD004034.pub4-BIB0113|cit113","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010775.pub2","article-title":"Montreal Cognitive Assessment for the diagnosis of Alzheimer\u2019s disease and other dementias","author":"Davis","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/sj.jhh.1001657","article-title":"Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on COgnition and Prognosis in the Elderly (SCOPE)","volume":"18","author":"Degl'Innocenti","year":"2004","journal-title":"Journal of Human Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/aje\/153.1.72","article-title":"Dementia and disability outcomes in large hypertension trials: lessons learned from the Systolic Hypertension in the Elderly Program (SHEP) trial","volume":"153","author":"Di Bari","year":"2001","journal-title":"American Journal of Epidemiology"},{"issue":"8","key":"10.1002\/14651858.CD004034.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0117|cit117","first-page":"352","article-title":"Untreated blood pressure is inversely related to cognitive functioning: the Framingham Study","volume":"138","author":"Elias","year":"1993","journal-title":"Journal of Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/01.HYP.0000145858.07252.99","article-title":"Blood pressure related cognitive decline: does age make a difference?","volume":"44","author":"Elias","year":"2004","journal-title":"Hypertension"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ajh\/hpy033","article-title":"Clinical trials of blood pressure lowering and antihypertensive medication: is cognitive measurement state-of-the-art?","volume":"31","author":"Elias","year":"2018","journal-title":"American Journal of Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/M17-1529","article-title":"Pharmacologic interventions to prevent cognitive decline, mild cognitive impairment, and clinical Alzheimer-type dementia: a systematic review","volume":"168","author":"Fink","year":"2018","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study","volume":"162","author":"Forette","year":"2002","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/0097840X.1976.9936068","article-title":"Underload and overload in working life: outline of a multidisciplinary approach","volume":"2","author":"Frankenhaeuser","year":"1976","journal-title":"Journal of Human Stress"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jash.2012.08.004","article-title":"Blood pressure and treatment of persons with hypertension as it relates to cognitive outcomes including executive function","volume":"6","author":"Gorelick","year":"2012","journal-title":"Journal of the American Society of Hypertension : JASH"},{"issue":"10","key":"10.1002\/14651858.CD004034.pub4-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the Atherosclerosis Risk in Communities Neurocognitive Study","volume":"71","author":"Gottesman","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/bmj.312.7034.805","article-title":"Low blood pressure and dementia in elderly people: the Kungsholmen project","volume":"312","author":"Guo","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneur.56.8.991","article-title":"Occurence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use","volume":"56","author":"Guo","year":"1999","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD004034.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"e038971","DOI":"10.1136\/bmjopen-2020-038971","article-title":"Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis","volume":"10","author":"Gupta","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1002\/14651858.CD004034.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1212\/01.WNL.0000129258.93137.4B","article-title":"Blood pressure and late-life cognitive function change: a biracial longitudinal population study","volume":"62","author":"Hebert","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"10.1002\/14651858.CD004034.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD004034.pub4-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2020.4249","article-title":"Association of blood pressure lowering with incident dementia or cognitive impairment: a systematic review and meta-analysis","volume":"323","author":"Hughes","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0132|cit132","first-page":"e67","article-title":"American Heart Association Council on Hypertension; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Stroke Council","volume":"68","author":"Iadecola","year":"2016","journal-title":"Hypertension"},{"issue":"19","key":"10.1002\/14651858.CD004034.pub4-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD004034.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1745-6215-10-57","article-title":"DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT","volume":"10","author":"Jones","year":"2009","journal-title":"Trials"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0136|cit136","first-page":"CD011971","article-title":"Antihypertensive withdrawal for the prevention of cognitive decline","volume":"11","author":"Jongstra","year":"2016","journal-title":"The Cochrane database of systematic reviews"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: the Cache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ageing\/29.3.243","article-title":"The association between low diastolic blood pressure in middle age and cognitive function in old age: a population based study","volume":"29","author":"Kilander","year":"2000","journal-title":"Age Ageing"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3233\/JAD-180288","article-title":"Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis","volume":"64","author":"Larsson","year":"2018","journal-title":"Journal of Alzheimer's disease"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: the Honolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis","volume":"31","author":"Levi Marpillat","year":"2013","journal-title":"Journal of Hypertension"},{"issue":"21","key":"10.1002\/14651858.CD004034.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1212\/WNL.0000000000003955","article-title":"Effect of a long-term intensive lifestyle intervention on prevalence of cognitive impairment","volume":"88","author":"Espeland","year":"2017","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1532-5415.2005.53015.x","article-title":"Alteration of a Clinically Meaningful Outcome in the Natural History of Alzheimer's Disease by Cholinesterase Inhibition","volume":"53","author":"Lopez","year":"2005","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical Diagnosis of Alzheimer\u2019s Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"4","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimer's & Dementia"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archneur.58.10.1640","article-title":"Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study","volume":"58","author":"Morris","year":"2001","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD004034.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00125-016-4118-x","article-title":"ACCORDION MIND: results of the observational extension of the ACCORD MIND randomised trial.","volume":"60","author":"Murray","year":"2017","journal-title":"Diabetologia"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0149|cit149","unstructured":"National Institute for Health and Care Excellence Hypertension in adults: diagnosis and management Guideline 2019"},{"issue":"7","key":"10.1002\/14651858.CD004034.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc11-1868","article-title":"Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial","volume":"35","author":"O'Connor","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1161\/01.STR.0000155686.73908.3e","article-title":"Efficacy and Safety of Nimodipine in Subcortical Vascular Dementia","volume":"36","author":"Pantoni","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2217\/fca.15.90","article-title":"The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis","volume":"12","author":"Parsons","year":"2016","journal-title":"Future Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD004034.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/HJH.0000000000000273","article-title":"A systematic review of calcium channel blocker use and cognitive decline\/dementia in the elderly","volume":"32","author":"Peters","journal-title":"Journal of Hypertension"},{"issue":"7","key":"10.1002\/14651858.CD004034.pub4-BIB0154|cit154","first-page":"Supplement, Pag","article-title":"INVESTIGATION OF ANTIHYPERTENSIVE CLASS EFFECTS ON DEMENTIA AND COGNITIVE DECLINE: A COLLABORATIVE META-ANALYSIS OF PARTICIPANT DATA","volume":"14","author":"Peters","journal-title":"Alzheimers & Dementia: The Journal of the Alzheimer's Associaiton"},{"issue":"21","key":"10.1002\/14651858.CD004034.pub4-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1212\/WNL.0000000000007543","article-title":"Blood pressure and dementia: What the SPRINT-MIND trial adds and what we still need to know","volume":"92","author":"Peters","year":"2019","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0156|cit156","unstructured":"Prince M Albanese E Guerchet M Prina M World Alzheimer Report 2014. Dementia and Risk Reduction: An Analysis Of Protective And Modifiable Factors London Alzheimer's Disease International"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archneur.60.2.223","article-title":"Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study","volume":"60","author":"Qiu","year":"2003","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.61.5.655","article-title":"Combined effects of APOE genotype, blood pressure and antihypertensive drug use on incident AD","volume":"61","author":"Qiu","year":"2003","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/01.STR.0000133128.42462.ef","article-title":"Decline in blood pressure over time and risk of dementia: a longitudinal study from the Kungsholmen Project","volume":"35","author":"Qiu","year":"2004","journal-title":"Stroke"},{"issue":"17","key":"10.1002\/14651858.CD004034.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1161\/CIR.0000000000000601","article-title":"Systematic Review for the 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"138","author":"Reboussin","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000051233","article-title":"Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study","volume":"12","author":"Ruitenberg","year":"2001","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"7","key":"10.1002\/14651858.CD004034.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/gps.2572","article-title":"Hypertension is a potential risk factor for vascular dementia: systematic review","volume":"26","author":"Sharp","year":"2011","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"9009","key":"10.1002\/14651858.CD004034.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(96)90608-X","article-title":"15-year longitudinal study of blood pressure and dementia","volume":"347","author":"Skoog","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1212\/WNL.51.4.986","article-title":"Association of midlife blood pressure to late-life cognitive decline and brain morphology","volume":"51","author":"Swan","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000076356","article-title":"Incidence and risk factors for mild cognitive impairment: a population based three-year follow-up study of cognitively healthy elderly subjects","volume":"17","author":"Tervo","year":"2004","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"issue":"9","key":"10.1002\/14651858.CD004034.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/HJH.0000000000001829","article-title":"Blood pressure-lowering interventions to prevent dementia: a systematic review and meta-analysis","volume":"36","author":"Van Middelaar","year":"2018","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1212\/01.WNL.0000098934.18300.BE","article-title":"Low blood pressure and the risk of dementia in very old individuals","volume":"61","author":"Verghese","year":"2003","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1161\/01.HYP.0000156744.44218.74","article-title":"Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging","volume":"45","author":"Waldstein","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11906-017-0724-3","article-title":"Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review","volume":"19","author":"Walker","journal-title":"Current Hypertension Reports"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.scds.2003.00.025","article-title":"Antihypertensive treatment and prevention of stroke and dementia","volume":"3","author":"Wang","year":"2003","journal-title":"Seminars in Cerebrovascular Diseases and Stroke"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12916-015-0328-1","article-title":"No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over","volume":"13","author":"Warwick","year":"2015","journal-title":"BMC Medicine"},{"issue":"4608","key":"10.1002\/14651858.CD004034.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.6867715","article-title":"Forms of memory failure","volume":"221","author":"Weingartner","journal-title":"Science"},{"issue":"6","key":"10.1002\/14651858.CD004034.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M16-1754","article-title":"Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older: A Systematic Review and Meta-analysis","volume":"166","author":"Weiss","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"17","key":"10.1002\/14651858.CD004034.pub4-BIB0175|cit175","first-page":"e426","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"138","author":"Whelton","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","article-title":"Midlife cardiovascular risk factors and risk of dementia in late life","volume":"64","author":"Whitmer","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0177|cit177","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992"},{"issue":"33","key":"10.1002\/14651858.CD004034.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0024-3205(02)02367-6","article-title":"Relationship between blood pressure and Alzheimer's disease in Linxian county","volume":"72","author":"Wu","year":"2003","journal-title":"Life Science"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1532-5415.2003.51117.x","article-title":"Association between dementia and midlife risk factors: the radiation effects research foundation adult health study","volume":"51","author":"Yamada","year":"2003","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neurobiolaging.2004.03.009","article-title":"Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging","volume":"26","author":"Yasar","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","article-title":"Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese study: the Hisayama Study","volume":"45","author":"Yoshitake","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD004034.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2016.02.036","article-title":"The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis","volume":"33","author":"Zhuang","year":"2016","journal-title":"Journal of Clinical Neuroscience"},{"issue":"2","key":"10.1002\/14651858.CD004034.pub4-BIB0184|cit184","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004034.pub2","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004034.pub4-BIB0185|cit185","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004034.pub3","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","author":"McGuinness","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:47:59Z","timestamp":1793710079000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004034.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":185,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004034.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}